课题基金 / 基金详情

EFFECT OF 12 WKS OF COLESEVELAM ON INSULIN SENSITIVITY & ORAL GLUCOSE ABSORPTION

EFFECT OF 12 WKS OF COLESEVELAM ON INSULIN SENSITIVITY & ORAL GLUCOSE ABSORPTION
12 周考来维仑对胰岛素敏感性的影响
批准号:
7724920
负责人:
Robert Roy Henry
金额:
$2.61万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

Robert Roy Henry的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 口服治疗研究中血糖控制不佳的2型糖尿病受试者 1. 评价每天给予3.8 g考来维仑持续12周对肝脏胰岛素敏感性的影响。 2. 评价考来维仑3.8 g每日给药持续12周对外周胰岛素敏感性的影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. In subjects with Type 2 diabetes with inadequate glycemic control on oral therapy study 1. Evaluate the effect of colesevelam 3.8 g administered daily for 12 weeks, on hepatic insulin sensitivity. 2. Evaluate the effect of colesevelam 3.8g administered daily for 12 weeks on peripheral insulin sensitivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
海外基金